A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

NCT ID: NCT05514054

This clinical trial is studying a new treatment called imlunestrant to see how well it works compared to standard hormone therapy for patients with early breast cancer. The patients being considere...

Recruiting

Phase: PHASE3 Conditions: Breast Neoplasms

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT05843643

This clinical trial is studying the safety and effectiveness of a medication called upadacitinib for adults with moderate to severe systemic lupus erythematosus (SLE), a disease that causes inflamm...

Recruiting

Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

NCT ID: NCT06144710

The SG301-SC Injection Safety Study is a clinical trial focused on evaluating a new treatment for people with Systemic Lupus Erythematosus (SLE), a condition where the immune system attacks the bod...

Recruiting

Phase: PHASE1 Conditions: Systemic Lupus Erythematosus (SLE)

A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

NCT ID: NCT06338995

The CONTRAST-NP clinical trial is studying a medication called lebrikizumab to see how well it works and how safe it is for adults with chronic rhinosinusitis and nasal polyps. This condition can c...

Recruiting

Phase: PHASE3 Conditions: Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

NCT ID: NCT06079879

This clinical trial is studying a new medication called bomedemstat (also known as MK-3543) to see if it works better than the best available treatments for people with essential thrombocythemia (E...

Recruiting

Phase: PHASE3 Conditions: Essential Thrombocythemia

A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

NCT ID: NCT05617677

This clinical trial is studying a medication called deucravacitinib to see how well it works and how safe it is for people with moderate to severe Systemic Lupus Erythematosus (SLE), a condition th...

Recruiting

Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)

NCT ID: NCT06161116

This clinical trial is studying a new treatment called MK-6194 for adults with Systemic Lupus Erythematosus (SLE), a condition where the immune system mistakenly attacks healthy tissues. The main g...

Recruiting

Phase: PHASE2 Conditions: Systemic Lupus Erythematosus

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

NCT ID: NCT06875310

The KRYSTAL-4 trial is studying a new treatment approach for patients with a specific type of lung cancer called non-small cell lung cancer (NSCLC) that has a mutation known as KRAS G12C. This tria...

Recruiting

Phase: PHASE3 Conditions: Carcinoma, Non-Small-Cell Lung

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

NCT ID: NCT05445778

The GLORIOSA clinical trial is studying a new treatment approach for patients with certain types of ovarian, fallopian tube, or peritoneal cancer who have responded well to previous platinum-based ...

Recruiting

Phase: PHASE3 Conditions: Ovarian Cancer, Fallopian Tube Cancer +1 more

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

NCT ID: NCT04613596

The KRYSTAL-7 trial is studying a new treatment for patients with advanced non-small cell lung cancer (NSCLC) that has a specific mutation called KRAS G12C. The trial has two parts: the Phase 2 par...

Recruiting

Phase: PHASE2 Conditions: Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

A Study of BL-M07D1 + Pertuzumab With or Without Taxane Versus Taxane + Trastuzumab and Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer

NCT ID: NCT06891833

This clinical trial is investigating a new treatment approach for women with HER2-positive breast cancer, which is a specific type of breast cancer that can grow more aggressively. The study is loo...

Recruiting

Phase: PHASE2 Conditions: HER2-positive Breast Cancer

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

NCT ID: NCT06671496

This clinical trial is studying a new medication called zasocitinib (also known as TAK-279) to see how well it works for adults with psoriatic arthritis (PsA). PsA is a long-term condition that cau...

Recruiting

Phase: PHASE3 Conditions: Psoriatic Arthritis

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

NCT ID: NCT05920356

This clinical trial, called CodeBreaK 202, is studying two different treatments for patients with advanced non-small cell lung cancer (NSCLC) that has a specific genetic mutation known as KRAS p. G...

Recruiting

Phase: PHASE3 Conditions: Non-Small Cell Lung Cancer (NSCLC)

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

NCT ID: NCT04649242

This clinical trial is looking at a new treatment called BHV-3000 for children and teenagers who suffer from moderate or severe migraines. The study aims to see if this medication is safe and effec...

Recruiting

Phase: PHASE3 Conditions: Pediatric Migraine

Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

NCT ID: NCT06241313

This clinical trial is studying a medication called atogepant, which is taken as a tablet, to see how well it works and how safe it is for adults who experience migraine attacks. Migraines are seve...

Recruiting

Phase: PHASE3 Conditions: Migraine

A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV

NCT ID: NCT06206720

This clinical trial is studying a new medication called Deuremidevir Hydrobromide to see how safe and effective it is for treating infants with Respiratory Syncytial Virus (RSV), a common virus tha...

Recruiting

Phase: PHASE2 Conditions: Respiratory Syncytial Virus Infection

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

NCT ID: NCT06929299

This clinical trial is studying a new treatment called STSA-1301, which is given as a subcutaneous (under the skin) injection. The goal is to find out how safe the treatment is, how the body proces...

Recruiting

Phase: PHASE1 Conditions: Primary Immune Thrombocytopenia (ITP)

Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer

NCT ID: NCT07008976

This clinical trial is studying a new treatment called TQB2102 for patients with advanced breast cancer that tests positive for a protein called HER2. This type of breast cancer can be more aggress...

Not yet recruiting

Phase: PHASE3 Conditions: Metastatic Breast Cancer

A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies

NCT ID: NCT07011186

This clinical trial is investigating the use of a new medication called TQB3909 tablets, combined with another drug called azacitidine, to treat certain blood cancers known as myeloid malignancies,...

Recruiting

Phase: PHASE1 Conditions: Myeloid Malignancy

BCG for Therapeutic Use Phase Ⅲ Clinical Trial

NCT ID: NCT06747455

This clinical trial is studying the use of a medication called Bacillus Calmette-Guérin (BCG) to help prevent the return of non-muscle-invasive bladder cancer after surgery. The trial is specifical...

Recruiting

Phase: PHASE3 Conditions: BCG

Main Menu

Clinical Trials in Bengbu, Anhui

100 Active Trials Found in Bengbu

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

A Study of BL-M07D1 + Pertuzumab With or Without Taxane Versus Taxane + Trastuzumab and Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer

A Clinical Trial of TQB3909 Tablets in Combination With Azacitidine for the Treatment of Myeloid Malignancies

BCG for Therapeutic Use Phase Ⅲ Clinical Trial